Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 855

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 855
---
 this loss. The Company did not have short-term investments during the year ended December 31, 2023. The contractual maturities of the Company’s short-term investments in available-for-sale securities held were as follows (in thousands):

| ​                   
 ​                   
 ​                   | ​ 
 ​ | ​            
 December 31, 
 2022         |      ​ |
|:--------------------|:--|:-------------|-------:|
| Due within one year | ​ | $            | 22,250 |

4. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following as of December 31, 2023 and 2022 (in thousands):

| ​                                               
 ​                                               | ​ 
 ​ | ​                  
 As of December 31, 
 ​                  |     ​ 
  2023 | ​ | ​ |    ​ 
 2022 |
|:------------------------------------------------|:--|:-------------------|------:|:--|:--|-----:|
| Prepaid research and development expenses       | ​ | $                  | 3,203 | ​ | $ |  314 |
| Other prepaid expenses                          | ​ | ​                  |    36 | ​ | ​ |   56 |
| Total prepaid expenses and other current assets | ​ | $                  | 3,239 | ​ | $ |  370 |

5. Intangible Assets Intangible assets consisted of the following as of December 31, 2023 and 2022 (in thousands):

| ​                              
 ​                              | ​ 
 ​ | ​                  
 As of December 31, 
 ​                  |    ​ 
 2023 | ​ | ​ |    ​ 
 2022 |
|:-------------------------------|:--|:-------------------|-----:|:--|:--|-----:|
| Licensed patent rights         | ​ | $                  |  826 | ​ | $ |  826 |
| Less: accumulated amortization | ​ | ​                  | -378 | ​ | $ | -315 |
| Total intangible assets, net   | ​ | $                  |  448 | ​ | $ |  511 |

As of December 31, 2023, the expected remaining amortization expense is as follows (in thousands):

| ​                       
 Year Ended December 31, 
 2024                    | ​ 
 ​ | ​      
 Amount |   ​ 
  63 |
|:------------------------|:--|:-------|----